The company strives to create an open, inclusive culture that empowers Precisioneers. It says shared values help its team pursue its mission of improving life through genome editing.
Before Thanksgiving break in 2004, as postdoctoral fellows at Duke University, Jeff Smith, Ph.D. and Derek Jantz, Ph.D. were excited about a new discovery – one that would lead to the foundation of the proprietary ARCUS genome editing platform and the founding of Precision BioSciences in 2006. Some of the first ARCUS editing successes were in corn, soybeans, cotton, and other crop plants. That heritage lives and thrives today in Elo Life Systems, an independent company focused on food and agricu
Precision BioSciences uses its ARCUS genome-editing technology to develop medicines designed to address and potentially cure hard-to-treat conditions, including rare genetic diseases.
Precision BioSciences’ privacy notice describes personal information collected through its website and how it is collected, used, and shared; it does not cover collection through other websites or means.
